Phosphorus Molybdate - Mineral Metabolism Applications

Acid molybdate reduction (340nm) quantifies 2.5-5.0 mg/dL phosphate across vitamin D deficiency, Fanconi syndrome, and hyperparathyroidism workflows.

Endocrinology laboratories confirm hypophosphatemia prompting FGF23 testing. Ascorbic acid prevents vanadate interference compromising osteomalacia diagnosis.

Quality control verifies molybdate stability, acid hydrolysis, and 24-month lyophilized shelf life. Endpoint method eliminates kinetic drift.